The global Renal Denervation (RDN) Therapy market was valued at US$ 964.6 million in 2022 and is projected to reach US$ 7815.7 million by 2029, at a CAGR of 34.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radio Frequency Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Renal Denervation (RDN) Therapy include Medtronic (Covidien), ReCor, Johnson & Johnson, Boston Scientific, Shanghai Golden Leaf Med Tec Co., Ltd, Bio-Heart, SyMap Medical, Venus Medtech and Shanghai Microport Ep Medtech Co.,Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Renal Denervation (RDN) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Denervation (RDN) Therapy. This report contains market size and forecasts of Renal Denervation (RDN) Therapy in global, including the following market information:
Global Renal Denervation (RDN) Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Denervation (RDN) Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Denervation (RDN) Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Renal Denervation (RDN) Therapy Market Segment Percentages, by Type, 2022 (%)
Radio Frequency
Ultrasonic
Global Renal Denervation (RDN) Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Renal Denervation (RDN) Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Renal Denervation (RDN) Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Renal Denervation (RDN) Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Denervation (RDN) Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Renal Denervation (RDN) Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic (Covidien)
ReCor
Johnson & Johnson
Boston Scientific
Shanghai Golden Leaf Med Tec Co., Ltd
Bio-Heart
SyMap Medical
Venus Medtech
Shanghai Microport Ep Medtech Co.,Ltd.
Cryofocus Medtech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Renal Denervation (RDN) Therapy, market overview.
Chapter 2: Global Renal Denervation (RDN) Therapy market size in revenue.
Chapter 3: Detailed analysis of Renal Denervation (RDN) Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Renal Denervation (RDN) Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Renal Denervation (RDN) Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Renal Denervation (RDN) Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Renal Denervation (RDN) Therapy Overall Market Size
2.1 Global Renal Denervation (RDN) Therapy Market Size: 2022 VS 2029
2.2 Global Renal Denervation (RDN) Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Renal Denervation (RDN) Therapy Players in Global Market
3.2 Top Global Renal Denervation (RDN) Therapy Companies Ranked by Revenue
3.3 Global Renal Denervation (RDN) Therapy Revenue by Companies
3.4 Top 3 and Top 5 Renal Denervation (RDN) Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Renal Denervation (RDN) Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Denervation (RDN) Therapy Players in Global Market
3.6.1 List of Global Tier 1 Renal Denervation (RDN) Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Renal Denervation (RDN) Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Renal Denervation (RDN) Therapy Market Size Markets, 2022 & 2029
4.1.2 Radio Frequency
4.1.3 Ultrasonic
4.2 By Type - Global Renal Denervation (RDN) Therapy Revenue & Forecasts
4.2.1 By Type - Global Renal Denervation (RDN) Therapy Revenue, 2018-2023
4.2.2 By Type - Global Renal Denervation (RDN) Therapy Revenue, 2024-2029
4.2.3 By Type - Global Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Renal Denervation (RDN) Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Renal Denervation (RDN) Therapy Revenue & Forecasts
5.2.1 By Application - Global Renal Denervation (RDN) Therapy Revenue, 2018-2023
5.2.2 By Application - Global Renal Denervation (RDN) Therapy Revenue, 2024-2029
5.2.3 By Application - Global Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Renal Denervation (RDN) Therapy Market Size, 2022 & 2029
6.2 By Region - Global Renal Denervation (RDN) Therapy Revenue & Forecasts
6.2.1 By Region - Global Renal Denervation (RDN) Therapy Revenue, 2018-2023
6.2.2 By Region - Global Renal Denervation (RDN) Therapy Revenue, 2024-2029
6.2.3 By Region - Global Renal Denervation (RDN) Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Renal Denervation (RDN) Therapy Revenue, 2018-2029
6.3.2 US Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.3.3 Canada Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.3.4 Mexico Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Renal Denervation (RDN) Therapy Revenue, 2018-2029
6.4.2 Germany Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.3 France Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.4 U.K. Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.5 Italy Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.6 Russia Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.4.8 Benelux Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Renal Denervation (RDN) Therapy Revenue, 2018-2029
6.5.2 China Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.5.3 Japan Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.5.4 South Korea Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.5.6 India Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Renal Denervation (RDN) Therapy Revenue, 2018-2029
6.6.2 Brazil Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.6.3 Argentina Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Renal Denervation (RDN) Therapy Revenue, 2018-2029
6.7.2 Turkey Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.7.3 Israel Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Renal Denervation (RDN) Therapy Market Size, 2018-2029
6.7.5 UAE Renal Denervation (RDN) Therapy Market Size, 2018-2029
7 Renal Denervation (RDN) Therapy Companies Profiles
7.1 Medtronic (Covidien)
7.1.1 Medtronic (Covidien) Company Summary
7.1.2 Medtronic (Covidien) Business Overview
7.1.3 Medtronic (Covidien) Renal Denervation (RDN) Therapy Major Product Offerings
7.1.4 Medtronic (Covidien) Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.1.5 Medtronic (Covidien) Key News & Latest Developments
7.2 ReCor
7.2.1 ReCor Company Summary
7.2.2 ReCor Business Overview
7.2.3 ReCor Renal Denervation (RDN) Therapy Major Product Offerings
7.2.4 ReCor Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.2.5 ReCor Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Renal Denervation (RDN) Therapy Major Product Offerings
7.3.4 Johnson & Johnson Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Company Summary
7.4.2 Boston Scientific Business Overview
7.4.3 Boston Scientific Renal Denervation (RDN) Therapy Major Product Offerings
7.4.4 Boston Scientific Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.4.5 Boston Scientific Key News & Latest Developments
7.5 Shanghai Golden Leaf Med Tec Co., Ltd
7.5.1 Shanghai Golden Leaf Med Tec Co., Ltd Company Summary
7.5.2 Shanghai Golden Leaf Med Tec Co., Ltd Business Overview
7.5.3 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Major Product Offerings
7.5.4 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.5.5 Shanghai Golden Leaf Med Tec Co., Ltd Key News & Latest Developments
7.6 Bio-Heart
7.6.1 Bio-Heart Company Summary
7.6.2 Bio-Heart Business Overview
7.6.3 Bio-Heart Renal Denervation (RDN) Therapy Major Product Offerings
7.6.4 Bio-Heart Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.6.5 Bio-Heart Key News & Latest Developments
7.7 SyMap Medical
7.7.1 SyMap Medical Company Summary
7.7.2 SyMap Medical Business Overview
7.7.3 SyMap Medical Renal Denervation (RDN) Therapy Major Product Offerings
7.7.4 SyMap Medical Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.7.5 SyMap Medical Key News & Latest Developments
7.8 Venus Medtech
7.8.1 Venus Medtech Company Summary
7.8.2 Venus Medtech Business Overview
7.8.3 Venus Medtech Renal Denervation (RDN) Therapy Major Product Offerings
7.8.4 Venus Medtech Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.8.5 Venus Medtech Key News & Latest Developments
7.9 Shanghai Microport Ep Medtech Co.,Ltd.
7.9.1 Shanghai Microport Ep Medtech Co.,Ltd. Company Summary
7.9.2 Shanghai Microport Ep Medtech Co.,Ltd. Business Overview
7.9.3 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Major Product Offerings
7.9.4 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.9.5 Shanghai Microport Ep Medtech Co.,Ltd. Key News & Latest Developments
7.10 Cryofocus Medtech
7.10.1 Cryofocus Medtech Company Summary
7.10.2 Cryofocus Medtech Business Overview
7.10.3 Cryofocus Medtech Renal Denervation (RDN) Therapy Major Product Offerings
7.10.4 Cryofocus Medtech Renal Denervation (RDN) Therapy Revenue in Global Market (2018-2023)
7.10.5 Cryofocus Medtech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
8
|
Pages :
97
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
8
|
Pages :
144
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
8
|
Pages :
131
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
8
|
Pages :
113
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
8
|
Pages :
92
|
View Report